Skip to main content
. 2013 Jul 9;9:1383–1387. doi: 10.3762/bjoc.9.154

Figure 1.

Figure 1

Marketed calcium-sensing receptor agonist cinacalcet (1), and CaSR antagonists Calhex 231 (2) and NPS 2143 ((R)-3).